P2b IMO should answer some questions as to whether

P2b IMO should answer some questions as to whether P is going to have any affect on psoriatic arthritis, since of the 199 trial patients a good number most likely have full blown psoriatic arthritis or at least symptoms of the disease.

Hope patients with same had some relief in pain for this condition during the trial showing that P definitely will have some application towards arthritis and other autoimmune diseases. Should show up on their Quality of Life questionnaire responses.

This would be quite a nice new development for Prurisol.